Review article · 2024 · Open access

Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics

Elsa El Abiad, Ali Al-Kuwari, Ubaida Al-Aani, Yaqoub Al Jaidah, Ali Châari

Cells, 13(22), 1901 · Published 18 November 2024 · DOI 10.3390/cells13221901

Open full textCite this paper

In brief

“Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics” is a 2024 review article by Elsa El Abiad and 4 co-authors, published in Cells. OpenAlex counts 21 citations as of 19 November 2026, which puts it in the top 2% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Cells.

Citations
21
Most cited in
2025 (11)
Field-weighted impact
0.99
References
158
Authors
5

Abstract

BACKGROUND: Alzheimer's disease (AD) affects a significant portion of the aging population, presenting a serious challenge due to the limited availability of effective therapies during its progression. The disease advances rapidly, underscoring the need for early diagnosis and the application of preventative measures. Current diagnostic methods for AD are often expensive and invasive, restricting access for the general public. One potential solution is the use of biomarkers, which can facilitate early detection and treatment through objective, non-invasive, and cost-effective evaluations of AD. This review critically investigates the function and role of biofluid biomarkers in detecting AD, with a specific focus on cerebrospinal fluid (CSF), blood-based, and saliva biomarkers. RESULTS: CSF biomarkers have demonstrated potential for accurate diagnosis and valuable prognostic insights, while blood biomarkers offer a minimally invasive and cost-effective approach for diagnosing cognitive issues. However, while current biomarkers for AD show significant potential, none have yet achieved the precision needed to replace expensive PET scans and CSF assays. The lack of a single accurate biomarker underscores the need for further research to identify novel or combined biomarkers to enhance the clinical efficacy of existing diagnostic tests. In this context, artificial intelligence (AI) and deep-learning (DL) tools present promising avenues for improving biomarker analysis and interpretation, enabling more precise and timely diagnoses. CONCLUSIONS: Further research is essential to confirm the utility of all AD biomarkers in clinical settings. Combining biomarker data with AI tools offers a promising path toward revolutionizing the personalized characterization and early diagnosis of AD symptoms.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

El Abiad, E., Al-Kuwari, A., Al-Aani, U., Al Jaidah, Y., & Châari, A. (2024). Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics. Cells, 13(22), 1901. https://doi.org/10.3390/cells13221901

MLA 9

El Abiad, Elsa, et al. “Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics.” Cells, vol. 13, no. 22, 2024, p. 1901. https://doi.org/10.3390/cells13221901.

Chicago

El Abiad, Elsa, Ali Al-Kuwari, Ubaida Al-Aani, Yaqoub Al Jaidah, and Ali Châari. 2024. “Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics.” Cells 13 (22): 1901. https://doi.org/10.3390/cells13221901.

Harvard

El Abiad, E. et al. (2024) ‘Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics’, Cells, 13(22), p. 1901. doi:10.3390/cells13221901.

IEEE

E. El Abiad, A. Al-Kuwari, U. Al-Aani, Y. Al Jaidah, and A. Châari, “Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics,” Cells, vol. 13, no. 22, p. 1901, 2024, doi: 10.3390/cells13221901.

BibTeX

@article{elabiad2024navigating,
  title     = {{Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics}},
  author    = {El Abiad, Elsa and Al-Kuwari, Ali and Al-Aani, Ubaida and Al Jaidah, Yaqoub and Châari, Ali},
  journal   = {Cells},
  year      = {2024},
  volume    = {13},
  number    = {22},
  pages     = {1901},
  doi       = {10.3390/cells13221901},
  url       = {https://doi.org/10.3390/cells13221901}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • Alzheimer's disease
  • biomarkers
  • biofluid biomarkers
  • cerebrospinal fluid biomarkers
  • blood biomarkers
  • salivary biomarkers
  • early diagnosis
  • non-invasive diagnosis

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

El Abiad, E., Al-Kuwari, A., Al-Aani, U., Al Jaidah, Y., & Châari, A. (2024). Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics. Cells, 13(22), 1901. https://doi.org/10.3390/cells13221901

How many times has this paper been cited?

21 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cells: sign in and open the full text from this page.

Who wrote this paper?

Elsa El Abiad, Ali Al-Kuwari, Ubaida Al-Aani, Yaqoub Al Jaidah, Ali Châari.

What is the DOI of this paper?

10.3390/cells13221901, permanently at https://doi.org/10.3390/cells13221901. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.